IL-33 and Soluble ST2 Are Associated With Recurrent Spontaneous Abortion in Early Pregnancy
- PMID: 35095557
- PMCID: PMC8793670
- DOI: 10.3389/fphys.2021.789829
IL-33 and Soluble ST2 Are Associated With Recurrent Spontaneous Abortion in Early Pregnancy
Abstract
Normal pregnancy is related to the successful transition from type 1 cellular immunity to type 2 cellular immunity. Therefore, this study aimed to investigate whether there is abnormal expression of cytokines in the process of inducing Recurrent spontaneous abortion (RSA). Interleukin (IL)-33 is a new member of the IL-1 family, and ST2, as IL-33's receptor, induced the production of type 2 cytokines. In this study, blood samples were collected from 19 non-pregnant women of normal childbearing age, 28 normal pregnant women, and 33 women with RSA. The serum concentrations of IL-33 and ST2 were detected by flow cytometry. Our results showed that the serum concentrations of IL-33 and ST2 in the RSA group were significantly higher than those in the healthy control group (IL-33: P < 0.05; ST2: P < 0.0001), and IL-33 and ST2 had a higher level in the process of RSA predictive value. In addition, this study initially found that the serum concentrations of IL-33 and ST2 were not significantly correlated with the number of weeks of pregnancy, and there was a lower correlation between IL-33 and ST2 during RSA. This result may be related to the small number of cases. This study is the first time to correlate the changes in serum concentrations of IL-33 and ST2 with RSA, which may be a novel biomarker for the prediction and treatment of RSA.
Keywords: IL-33; ST2; biomarker; diagnosis; recurrent spontaneous abortion.
Copyright © 2022 Zhao, Fu, Ding, Liu, Li, Song and Fu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial.Eur J Clin Pharmacol. 2023 May;79(5):627-634. doi: 10.1007/s00228-023-03473-9. Epub 2023 Mar 13. Eur J Clin Pharmacol. 2023. PMID: 36912957 Clinical Trial.
-
IL-33/ST2 axis affects the polarization and efferocytosis of decidual macrophages in early pregnancy.Am J Reprod Immunol. 2018 Jun;79(6):e12836. doi: 10.1111/aji.12836. Epub 2018 Mar 3. Am J Reprod Immunol. 2018. PMID: 29500844
-
Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions.Hum Reprod. 2000 Sep;15(9):2011-7. doi: 10.1093/humrep/15.9.2011. Hum Reprod. 2000. PMID: 10967006
-
[Relationship between recurrent spontaneous abortion and the level of interferon-γ and interleukin-4 in peripheral blood and gingival crevicular fluid of patients with chronic periodontitis].Zhonghua Kou Qiang Yi Xue Za Zhi. 2013 Mar;48(3):150-4. Zhonghua Kou Qiang Yi Xue Za Zhi. 2013. PMID: 23751529 Chinese.
-
Activated γδ T Cells With Higher CD107a Expression and Inflammatory Potential During Early Pregnancy in Patients With Recurrent Spontaneous Abortion.Front Immunol. 2021 Aug 17;12:724662. doi: 10.3389/fimmu.2021.724662. eCollection 2021. Front Immunol. 2021. PMID: 34484234 Free PMC article.
Cited by
-
IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition.Mol Med. 2023 Jul 4;29(1):88. doi: 10.1186/s10020-023-00668-9. Mol Med. 2023. PMID: 37403020 Free PMC article.
-
Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss.Front Genet. 2022 Sep 2;13:925652. doi: 10.3389/fgene.2022.925652. eCollection 2022. Front Genet. 2022. PMID: 36118846 Free PMC article.
-
Interleukins IL33/ST2 and IL1-β in Intrauterine Growth Restriction and Seropositivity of Anti-Toxoplasma gondii Antibodies.Microorganisms. 2024 Jul 12;12(7):1420. doi: 10.3390/microorganisms12071420. Microorganisms. 2024. PMID: 39065188 Free PMC article.
-
Asthma and risk of adverse pregnancy outcomes: A Mendelian randomization study.Heliyon. 2024 Jun 28;10(13):e33857. doi: 10.1016/j.heliyon.2024.e33857. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39044964 Free PMC article.
-
Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial.Eur J Clin Pharmacol. 2023 May;79(5):627-634. doi: 10.1007/s00228-023-03473-9. Epub 2023 Mar 13. Eur J Clin Pharmacol. 2023. PMID: 36912957 Clinical Trial.
References
LinkOut - more resources
Full Text Sources